Contract Notice Detail
Summary Information
Summary Information
Request Reference:
31/2345/2024
Request Name:
Medicamento Carboximaltose férrica 50 mg/ml Sol inj Fr 20 ml IV
Phase:
Tendering Phase
State:
Awarded
Description:
31/2345/2024 - Medicamento Carboximaltose férrica 50 mg/ml Sol inj Fr 20 ml IV
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
C1688 - CARBOXIMALTOSE FÉRRICA [50 MG/ML; 20 ML; SOL INJ; F/AMP]
-
277
(
Days
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua Leão Penedo 8000-386 União das freguesias de Faro (Sé e São Pedro) Faro PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
3/22/2024 9:13 AM
(UTC 0 hours)
National official publishing date and time (DR):
5/29/2023 12:00 AM
(UTC +1 hour)
Due datetime for receiving replies:
3/25/2024 5:00 PM
(UTC 0 hours)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
31000023452024.xlsx
31000023452024.xlsx
Download
convite 258º.pdf
convite 258º.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
Vision
1
Título do Lote
C1688 - CARBOXIMALTOSE FÉRRICA [50 MG/ML; 20 ML; SOL INJ; F/AMP]
1.1
Bill of Quantities
Esta lista de preços tem requisitos adicionais. Certifique-se de que tudo está completo em cada linha de artigo.
Código
Descrição
Qt
Unidade
C1688
CARBOXIMALTOSE FÉRRICA [50 MG/ML; 20 ML; SOL INJ; F/AMP]
3 000,000000
UN
Comentários
516677586 | Vifor Pharma Portugal, S.A. | CPA:2023481/2283/0176 | NºAIM:5588751;
Totais
(Os valores mostrados não incluem IVA)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Multifator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - C1688 - CARBOXIMALTOSE FÉRRICA [50 MG/ML; 20 ML; SOL INJ; F/AMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Price
Preço
100%
Normas de desempate
Definir normas de desempate?
Sim
Não
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...